Jillian E. Halladay, RN, MSc, PhD(c), Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. James MacKillop, PhD, Peter Boris Centre for Addictions Research, Psychiatry & Behavioural Neurosciences, and Michael G. Degroote Centre for Medicinal Cannabis Research, McMaster University/St. Joseph's Healthcare Hamilton, Ontario, Canada. Catharine Munn, MSc, MD, FRCP(c), Department of Psychiatry and Behavioural Neurosciences, Peter Boris Centre for Addictions Research, and Michael G. Degroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, Ontario, Canada. Susan M. Jack, RN, PhD, School of Nursing and Department of Health Research Methods, Evidence, and Impact, Offord Centre for Child Studies, McMaster University, Hamilton, Ontario, Canada. Katholiki Georgiades, PhD, Department of Psychiatry and Behavioural Neurosciences, Department of Health Research Methods, Evidence, and Impact, Offord Centre for Child Studies, David R. (Dan) Offord Chair in Child Studies, McMaster University, Hamilton, Ontario, Canada.
J Addict Nurs. 2020 Apr/Jun;31(2):92-101. doi: 10.1097/JAN.0000000000000334.
Psychiatric disorders and substance use disorders commonly co-occur and are major public health concerns given the morbidity and mortality associated with them. Globally, cannabis is among the most commonly used drugs, and cannabis use frequently begins in adolescence or emerging adulthood, both important periods of development and periods in which psychiatric symptoms and disorders frequently emerge. Thus, the relationships between cannabis use and mental illnesses are essential for nurses and other healthcare professionals and researchers to explore and understand. This literature review examines the relationships between cannabis use and depression, anxiety, and suicide. It includes a primer on the neurobiology of cannabis effects; an overview on the epidemiological evidence on the associations between cannabis use and depression, anxiety, and suicide; and a discussion of implications for nurses, particularly important given changes in the medical and recreational cannabis legislation in North America. Overall, this review found consistent evidence showing a cross-sectional association between recreational cannabis use and depression, anxiety, and suicide, despite some limitations and conflicts in the literature. In addition, most evidence from longitudinal or case control studies suggested cannabis use preceded the development of depressive symptoms and suicidal behaviors, although the quality of this evidence was mixed. Implications for future research and nursing practice are discussed.
精神障碍和物质使用障碍通常同时发生,并且由于与之相关的发病率和死亡率,这是主要的公共卫生关注点。在全球范围内,大麻是最常使用的药物之一,大麻使用通常始于青少年或成年早期,这两个时期都是重要的发展时期,也是精神症状和障碍经常出现的时期。因此,大麻使用与精神疾病之间的关系对于护士和其他医疗保健专业人员和研究人员来说是必不可少的,需要加以探索和理解。本文献综述探讨了大麻使用与抑郁、焦虑和自杀之间的关系。它包括大麻影响的神经生物学基础;大麻使用与抑郁、焦虑和自杀之间关联的流行病学证据概述;以及对护士的意义的讨论,鉴于北美医用和娱乐用大麻立法的变化,这一点尤为重要。总的来说,尽管文献中存在一些局限性和冲突,但这项综述发现了一致的证据,表明娱乐性大麻使用与抑郁、焦虑和自杀之间存在横断面关联。此外,大多数来自纵向或病例对照研究的证据表明,大麻使用先于抑郁症状和自杀行为的发展,尽管这些证据的质量参差不齐。讨论了对未来研究和护理实践的影响。